This page shows the latest Mydayis news and features for those working in and with pharma, biotech and healthcare.
The company’s new neuroscience division will look to build on its ADHD heritage and newer products like Intuniv, Vyvanse and Mydayis, the latter of which was recently launched in the
Mydayis will reach the US market in the third quarter of the year. ... After more than a decade, Shire has finally won approval in the US for its long-acting attention deficit hyperactivity disorder drug (ADHD) Mydayis.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...